Literature DB >> 8899007

Soluble CD44 variants in serum of patients with prostate cancer and other urological malignancies.

M Lein, S Weiss, K Jung, D Schnorr, S Loening.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8899007     DOI： 10.1002/(SICI)1097-0045(199611)29:5<334::AID-PROS9>3.0.CO;2-9

Source DB:  PubMed          Journal:  Prostate        ISSN： 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  2 in total

1.  High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.

Authors:  A G Zeimet; M Widschwendter; M Uhl-Steidl; E Müller-Holzner; G Daxenbichler; C Marth; O Dapunt
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.

Authors:  D Masson; M G Denis; M Denis; D Blanchard; M J Loirat; E Cassagnau; P Lustenberger
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.